Benzinga | May 13, 2021 04:26PM EDT

Eton Pharmaceuticals Q1 EPS $0.19, Inline, Sales $11.90M Miss $12.05M Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a 138 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $11.90 million which missed the analyst consensus estimate of $12.05 million by 1.24 percent. This is a 11.92K percent increase over sales of $99.00 thousand the same period last year.